The combination of neoantigen quality and T lymphocyte infiltrates identifies glioblastomas with the longest survival

Glioblastoma (GBM) is resistant to multimodality therapeutic approaches. A high burden of tumor-specific mutant peptides (neoantigens) correlates with better survival and response to immunotherapies in selected solid tumors but how neoantigens impact clinical outcome in GBM remains unclear. Here, we...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Commun Biol
Main Authors: Zhang, Jing, Caruso, Francesca P., Sa, Jason K., Justesen, Sune, Nam, Do-Hyun, Sims, Peter, Ceccarelli, Michele, Lasorella, Anna, Iavarone, Antonio
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6478916/
https://ncbi.nlm.nih.gov/pubmed/31044160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-019-0369-7
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki